Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03986281 · ClinicalTrials.gov registry record · NA

A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch

A NA study of Hypertension and Surgery, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
56
Enrollment target
1
Study location

NCT03986281 is a NA study of Hypertension and Surgery that has completed, run by The Cleveland Clinic. The registered enrollment target is 56 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03986281, a NA study of Hypertension and Surgery, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The accuracy of devices like the recent FDA-clearance of the Omron HeartGuide™ Blood Pressure sensor in robust clinical settings remain in question and thus form the underpinning of this research study. The objective of this pilot prospective study is to assess the accuracy of the Omron Blood Pressure sensor as compared to arterial line blood pressure monitoring.

Interventions

  • OTHER Omron Wearable Device
  • OTHER Standard Arterial Line

Study Locations (1)

Ohio

  • Cleveland Clinic - Cleveland

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2019-05-20
Est. Completion 2019-12-10
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT03986281

The ClinicalTrials.gov registry entry for NCT03986281 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (98% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Omron Wearable Device is the first listed.

NCT03986281 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT03986281 about?

NCT03986281 is a clinical study titled "A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch". The accuracy of devices like the recent FDA-clearance of the Omron HeartGuide™ Blood Pressure sensor in robust clinical settings remain in question and thus form the underpinning of this research study. The objective of this pilot prospective study is to assess the accuracy of the Omron Blood Press...

What is the current status of trial NCT03986281?

This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2019-05-20. Estimated completion is 2019-12-10.

What conditions does trial NCT03986281 study?

This clinical trial studies the following conditions: Hypertension, Surgery, Cardiac Disease.

What interventions are being tested in trial NCT03986281?

The interventions under investigation include: Omron Wearable Device (OTHER), Standard Arterial Line (OTHER).

Who is sponsoring clinical trial NCT03986281?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03986281 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.